Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reducing Hemarthrosis in Tibial Tubercle Osteotomy by the Administration of Intravenous Tranexamic Acid

NCT03606109 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT03606109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03606109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reducing Hemarthrosis in Tibial Tubercle Osteotomy by the Administration of Intravenous Tranexamic Acid
Lead sponsor
NYU Langone Health
Phase
Phase 4
Overall status
Completed
Start date
June 26, 2018
Completion date
June 2, 2021
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tibial tubercle osteotomy